These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24157055)

  • 1. Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA).
    Yano Y; Briasoulis A; Bakris GL; Hoshide S; Wang JG; Shimada K; Kario K
    J Am Soc Hypertens; 2014 Feb; 8(2):103-16. PubMed ID: 24157055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular protection and blood pressure reduction: a meta-analysis.
    Staessen JA; Wang JG; Thijs L
    Lancet; 2001 Oct; 358(9290):1305-15. PubMed ID: 11684211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies.
    Briasoulis A; Agarwal V; Tousoulis D; Stefanadis C
    Heart; 2014 Feb; 100(4):317-23. PubMed ID: 23813846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and stroke: an overview of published reviews.
    Lawes CM; Bennett DA; Feigin VL; Rodgers A
    Stroke; 2004 Mar; 35(3):776-85. PubMed ID: 14976329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
    Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
    J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
    Bangalore S; Kumar S; Volodarskiy A; Messerli FH
    Heart; 2013 May; 99(9):601-13. PubMed ID: 22914531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to the treatment of hypertension in older persons.
    Aronow WS
    Postgrad Med; 2012 Jan; 124(1):50-9. PubMed ID: 22314114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Cavazzini C; Furberg CD
    Lancet; 2000 Dec; 356(9246):1949-54. PubMed ID: 11130522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
    Suzuki H; Kanno Y;
    Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Bangalore S; Toklu B; Gianos E; Schwartzbard A; Weintraub H; Ogedegbe G; Messerli FH
    Am J Med; 2017 Jun; 130(6):707-719.e8. PubMed ID: 28109971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.